Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey ...
Hosted on MSN
Why is Moderna (MRNA) stock rocketing higher today?
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's positive momentum continued as the Coalition for Epidemic Preparedness Innovations (CEPI) ...
Zacks Investment Research on MSN
Moderna (MRNA) soars 10.9%: Is further upside left in the stock?
Moderna MRNA shares soared 10.9% in the last trading session to close at $35.66. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Moderna now anticipates ending 2025 with cash and cash equivalents worth $8.1 billion, up from its previous forecast of ...
Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading this week, for the July 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback